Addiction

Article	Citations
Commentary on Savinkina et al.: Reforming drug ‘detox’ centers—what will it entail and where do we begin?	132
Domestication of drinking: a survey study of changes in types of drinking occasions during periods of increasing and decreasing alcohol consumption in the 2000s in Finland	126
Issue Information	108
Issue Information	104
Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents	81
Re: The association between glucose‐dependent insulinotropic polypeptide and/or glucagon‐like peptide‐1 receptor agonist prescriptions and substance‐related outcomes in patients with opioid and alcoho	78
Self‐reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities	74
Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States	72
The effectiveness of workplace interventions for the prevention of alcohol use: A meta‐analysis	71
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	69
Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder	67
How does the influence of the cannabis industry differ from that of alcohol and tobacco?	65
Transitions to polysubstance use: Prospective cohort study of adolescents in Australia	64
Misleading conclusion from limited research approach: Comment on Manthey et al. ‘Restricting alcohol marketing to reduce alcohol consumption: A systematic review of the empirical evidence for o	63
Co‐action and changes in alcohol use during a smoking cessation attempt	60
Substance use treatment completion and criminal justice system contact in Chile: A retrospective, linked data cohort study	58
The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks	58
Understanding the mechanisms of change in social norms around tobacco use: A systematic review and meta‐analysis of interventions	57
Commentary on Nower et al: The Pathways Model should apply to non‐clinical gambling patterns	56
Commentary on Chai et al: Drug use, self‐harm, suicide, and use of registry data in epidemiological research	53
Commentary on Kunas et al.: Hijacked brain reward systems—how methodological advances can help to bridge gaps in the translational science pipeline	49
Referees	49
Issue Information	49
Alcohol: No Ordinary Commodity—a summary of the third edition	48
Will Australia's tightened prescription system reduce nicotine vaping among young people?	48

Assessing the impacts of alcohol outlets on crime as a natural experiment: agglomeration, churning and spatial effects	47
Commentary on Brummer et al.: When using screening tools, it is important to be aware of what you are screening for	43
Minimum unit pricing and the messiness of evidence‐based policy	42
When should we conduct large‐scale evaluations?	42
Prenatal areca nut consumption: overlooked aspects of a widely embraced habit	41
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review	39
Electronic cigarettes and subsequent cigarette smoking in young people: A systematic review	39
The ability of the UK population surveys to capture the true nature of the extent of gambling‐related harm	39
Issue Information	38
Reduction in smoking prevalence and e‐cigarettes: an English exception?	38
Promoting addiction science after Brexit—what can Addiction and SSA do and what does UK government need to do?	38
The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol	38
Issue Information	37
Issue Information	37
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	37
Peer‐ and web‐based interventions for risky drinking among US National Guard members: Mission Strong randomized controlled trial	37
The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic	36
Commentary on Edwards et al.: Alcohol use disorder—a different impact in young adulthood than later?	36
Commentary on Perry et al.: New means, new measures—without discarding all the previous ones!	35
Issue Information	34
Cannabis: Global Histories by Lucas Richert and James H. Mills, editors	34
Commentary on Lange et al.: Acute alcohol use before suicide—is it contributing to an increase in suicide rates in the United States?	33
Safety of e‐cigarettes and nicotine patches as stop‐smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E‐cigarettes and Patches (PREP) randomized controlled trial	33
Future Directions for the International Cannabis Toolkit (iCannToolkit)	33
Redefining and categorizing emergency medical service opioid‐related incidents in Massachusetts	33
Nitrous oxide: The label ‘potentially addictive’ may do more harm than good	32
Evidence for a hijacked brain reward system but no desensitized threat system in quitting‐motivated smokers: An fMRI study	32
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	31
Strengthening oversight and integrity: The multi‐faceted role of centralized player tracking systems in gambling	31
Closing the research‐to‐implementation gap for contingency management as an effective intervention for substance use disorders across diverse communities	30
Virtual contingency management, what is it worth and who will pay for it?	30
Addiction Lives: Robert West	30
Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta‐analysis	29
Addiction Lives: Maggie Brady	29
The old and familiar meets the new and unknown: patient and clinician perceptions on e‐cigarettes for smoking reduction in UK general practice, a qualitative interview study	29
Issue Information	28
Commentary on Rivera‐Aguirre et al.: What are the effects of cannabis legalization on youth use? It may depend on what you mean by ‘legalization’	28
Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021	27
Why do we focus on the exception and not the rule? Examining the prevalence of mono‐ versus polysubstance use in the general population	27
Trends and patterns of dual use of combustible tobacco and e‐cigarettes among adults in England: A population study, 2016–2024	27
Systematic review and meta‐analyses of cytisine to support tobacco cessation	27
Will Australia's tightened prescription system reduce nicotine vaping among young people?	26
Issue Information	26
Predictors of alcohol and other drug treatment completion among young people accessing residential and community‐based treatment: A retrospective analysis of routinely collected service data	26
Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map	26
Coordinating cannabis data collection globally: Policy implications	25
Recognizing the complexities of co‐prescriptions and life‐style factors in opioid agonist treatment: A response from Eleni Domzaridou, Matthew J. Carr, Tim Millar, Roger T. Webb and Darren M. Ashcroft	25
Effects of e‐cigarette use on mental health among youths: quasi‐experimental evidence from Canada	24
Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	24
Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial	24

Issue Information	24
The iCannToolkit: a tool to embrace measurement of medicinal and non‐medicinal cannabis use across licit, illicit and cross‐cultural settings	23
Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	23
Longitudinal trajectories of substance use disorder treatment use: A latent class growth analysis using a national cohort in Chile	23
Issue Information	22
An evaluation of naloxone transit for opioid overdose using drones: A case study using real‐world coroner data	22
Impact of vaping restrictions in public places on smoking and vaping in the United States—evidence using a difference‐in‐differences approach	22
Issue Information	22
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	22
Commentary on Beard et al.: Using survey data to test the hypothesis that e‐cigarettes are a gateway to cigarette smoking in youth	22
	22
Issue Information	21
Postoperative buprenorphine continuation in stabilized buprenorphine patients: A population cohort study	21
Influence of vaccination on adverse health outcomes after SARS‐CoV‐2 infection among individuals with alcohol use disorder: a population‐based study	21
Addiction: A treatise from 1561	21
Issue Information	21
Commentary on Staff et al.: Should smoke‐free areas be made vape‐free?	20
Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions	20
Commentary on Kumar et al.: The importance of conceptual clarity and alignment between constructs and measurements in social cognition research in addiction	20
Drinking motives, personality traits and life stressors—identifying pathways to harmful alcohol use in adolescence using a panel network approach	20
Commentary on Loud et al.: Reconsidering nicotine dependence in adults	20
Cigarette pack size and consumption: a randomized cross‐over trial	20
‘A man can only be truly known in drunkenness and war.’ An anthropological perspective on alcohol use during the Portuguese Colonial War	19
Predictors of early and sustained cessation of heavy drinking over 5 years among adult primary care patients	19
Commentary on Victor et al. : Preventing overdose deaths following release from incarceration—context is crucial	19
Commentary on Lo‐Ciganic et al.: The importance of evidence‐based clinical and policy approaches to reduce opioid harms	19
Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers	19
Austin Bradford Hill’s ‘Environment and disease: Association or causation’	19
Alcohol consumption in India: a systematic review and modelling study for sub‐national estimates of drinking patterns	19
Overestimation of alcohol consumption norms as a driver of alcohol consumption: a whole‐population network study of men across eight villages in rural, southwestern Uganda	18
Motivational interviewing and problem‐solving therapy intervention for patients on antiretroviral therapy for HIV in Tshwane, South Africa: A randomized controlled trial to assess the impact on alcoho	18
All alcohol exposure counts ‐ testing parental, older sibling, best friend and peer exposure on young adolescent drinking in a seven‐wave longitudinal study	18
Issue Information	18
Education matters: longitudinal pathways to mid‐life heavy drinking in a national cohort of black Americans	18
Cutting down, quitting and motivation to stop smoking by self‐reported COVID‐19 status: Representative cross‐sectional surveys in England	18
Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact	18
Integrated care van delivery of evidence‐based services for people who inject drugs: A cluster‐randomized trial	18
Does heroin‐assisted treatment reduce crime? A review of randomized‐controlled trials	18
Longer‐term impacts of trading restrictions on alcohol‐related violence: insights from New South Wales, Australia	17
Personalized chat‐based support for smoking cessation among smokers with mental health symptoms in the workplace: A randomized controlled trial	17
	17
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	17
Recent decline in Chinese alcohol production and consumption: Potential contributing factors and the role of globally recommended measures	17
Use of disposable e‐cigarettes among youth who vape in Canada, England and the United States: Repeat cross‐sectional surveys, 2017–2023	17
Commentary on Keller‐Hamilton et al. : Oral nicotine pouches provide a less controversial route for tobacco harm reduction than electronic cigarettes	16
Naloxone administration—no balance without titration	16
Gabapentinoids: repeating mistakes of the past?	16
Over a decade later and Addiction journal is still committed to publishing qualitative research	16
An Addiction series on regional perspectives on addiction‐related problems	16
Recommendations for future research exploring e‐cigarette use and later cigarette smoking in young people: Results from a consultation exercise	16
Relapse in substance‐induced psychosis and associated risk factors. A Nationwide register‐linkage study from Sweden	16
Polygenic score for cigarette smoking is associated with ever electronic‐cigarette use in a college‐aged sample	16
Stigma and gaming disorder: should we take a ‘glass half full’ or ‘glass half empty’ perspective?	16
Socio‐economic inequalities in smoking and drinking in adolescence: Assessment of social network dynamics	16
Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014–2021	16
Affected other interventions: a systematic review and meta‐analysis across addictions	16
Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study	16
Characteristics and ingredients of disposable ‘Elfbar’ e‐cigarettes sold in the United States and the United Kingdom	16
Behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India and Pakistan: A pilot randomized controlled trial	16
Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data	16
Accurate and sufficient measurement of cannabis and tobacco co‐use: agreement, consensus and the path forward	16
Prevalence of pharmacotherapy for attention‐deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students	16
National profile on substance use, substance use‐related problems and policy: The case of Chile	16
Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling	16
Alcohol use as a predictor of intimate partner violence in emerging adulthood: A dyadic daily diary investigation	15
Commentary on Pessar et al.: ‘Downscaling’ United States state cannabis policy to investigate environmental and social impacts on cannabis use	15
Why it is important to conduct gambling research that is fair and free from conflicts of interest	15
	15
Public health considerations about tetrahydrocannabinol‐infused beverages	15
The shape of gambling risk‐curves for frequency, expenditure and proportion of income in Australia	15
Mapping consumptions and market size of cocaine, amphetamine and MDMA through wastewater analysis: A Dutch case study	15
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	15
Artificial intelligence‐based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine‐type stimulant use disorder	15
Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	15
How substance use prevention research gets used in United States federal policy	14
Maternal and child genetic liability for smoking and caffeine consumption and child mental health: an intergenerational genetic risk score analysis in the ALSPAC cohort	14
Non‐alcoholic beverage consumption among US adults who consume alcohol	14
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	14
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	14
How do people quit smoking using e‐cigarettes? A mixed‐methods exploration of participant smoking pathways following receiving an opportunistic e‐cigarette‐based smoking cessation intervention	14

Commentary on Östh et al.: Sensor‐based approaches to inform alcohol interventions – beyond BAC	14
What can we learn from the history of research on psychedelic drugs in the addictions?	14
Changes in drinking days among United States adults during the COVID‐19 pandemic	14
Harm perceptions of nicotine‐containing products and associated sources of information in UK adults with and without mental ill health: A cross‐sectional survey	14
The risks of misclassifying addictive food substances as non‐addictive	14
The National Academy of Sciences ‘Clearing the Smoke: assessing the Science Base for tobacco harm reduction’. Washington DC, National Academy Press, 2001	14
Use of the BACtrack Skyn alcohol biosensor: Practical applications for data collection and analysis	14
Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study	14
Commentary on Brennan et al.: Pros and cons of minimum unit price for alcohol	14
The efficacy and tolerability of pharmacologically active interventions for alcohol‐induced hangover symptomatology: a systematic review of the evidence from randomised placebo‐controlled trials	14
Prevalence of use and real‐world effectiveness of smoking cessation aids during the COVID‐19 pandemic: a representative study of smokers in England	14
Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study	14
Commentary on Chambers et al.: Investigating the use of peer support services in substance use disorders treatment	14
US tobacco companies selectively disseminated hyper‐palatable foods into the US food system: Empirical evidence and current implications	14
Brain structural covariance network differences in adults with alcohol dependence and heavy‐drinking adolescents	13
GLP‐1R agonist medications for addiction treatment	13
Insights from biosurveillance: non‐fatal opioid overdoses in Rhode Island 2019–21	13
Do not conflate debates on regulating therapeutic use of psychotropic substances with those on the legalization of their non‐therapeutic use	13
Commentary on Stam et al.: The substantial and dynamic contribution of opioid potency to total overdose risk	13
Classifying alcohol control policies enacted between 2000 and 2020 in Poland and the Baltic countries to model potential impact	13
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials	13
Disentangling the messiness of natural experiments to evaluate public policy	13
Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study	13
Rare but relevant series	13
Hazardous and harmful alcohol use in the Northern Territory, Australia: the impact of alcohol policy on critical care admissions using an extended sampling period	13
Mortality in substance‐induced psychosis: a register‐based national cohort study	12
The environmental impact of tobacco products: Time to increase awareness and action	12
Clinical management of the alcohol withdrawal syndrome	12
Does a local Alcohol Health Champion programme have a measurable impact on health and crime outcomes? A natural experiment evaluation of Communities in Charge of Alcohol (CICA) based on triangulation	12
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia,	12
Cannabis and sport: A World Anti‐Doping perspective	12
The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment	12
Disposable e‐cigarettes: Prevalence of use in Germany from 2016 to 2023 and associated user characteristics	12
E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study	12
Prescribing psychologists: Forgotten providers in the battle against opioid use disorder	12
What lessons from Norway's experience could be applied in the United States in response to the addiction and overdose crisis?	12
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	11
Correction to “How do we determine the impact of e‐cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor”	11
Did the under‐reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?	11
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	11
Alcohol‐specific inhibition training in patients with alcohol use disorder: a multi‐centre, double‐blind randomized clinical trial examining drinking outcome and working mechanisms	11
Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study	11
Let's talk about pleasure: Bridging the sociology and public health divide	11
Taking pleasure seriously: Should alcohol research say more about fun?	11
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review	11
Society for the Study of Addiction Annual Conference 2024	11
Casino accessibility and suicide: A county‐level study of 50 US states, 2000 to 2016	11
Correction to “The need for a comprehensive framework”	11
Does the decline in Swedish adolescent drinking persist into early adulthood?	11
Trends and projection in the proportion of (heavy) cannabis use in Germany from 1995 to 2021	11
Reducing barriers to the hepatitis C care cascade in prison via point‐of‐care RNA testing: a qualitative exploration of men in prison using an integrated framework	11
Experimental manipulations of behavioral economic demand for addictive commodities: a meta‐analysis	11
Effects of a minimal‐guided on‐line intervention for alcohol misuse in Estonia: a randomized controlled trial	11
Current and future trends in the consumption, sale and purchasing of alcohol‐free and low‐alcohol products in Great Britain, 2014 to 2023	11
Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society	11
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study	11
Cannabis use in sub‐Saharan Africa: A systematic review and meta‐analysis	11
Does the preparation for intravenous administration affect the composition of heroin injections? A controlled laboratory study	10
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	10
Adult smokers’ discussions about vaping with health professionals and subsequent behavior change: a cohort study	10
Evaluation of monitoring youth exposure to alcohol advertising on cable television, United States 2016–19	10
Issue Information	10
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial	10
Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta‐analysis of its follow‐up effects	10
A systematic review and meta‐analysis of the relationship between youth drinking, self‐posting of alcohol use and other social media engagement (2012–21)	10
Aldous Huxley'sThe Doors of Perception	10
A critique of the Australian National Health and Medical Research Council CEO statement on electronic cigarettes	10
Social and structural determinants of injection drug use‐associated bacterial and fungal infections: A qualitative systematic review and thematic synthesis	10
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study	10
Alcohol consumption trajectories over the Australian life course	10
Issue Information	10
	10
The association of lowered alcohol prices with birth outcomes and abortions: A population‐based natural experiment	10
Effect of nicotine mouth spray on urges to vape: A randomized, placebo‐controlled, pharmacodynamic clinical trial in exclusive e‐cigarette users	9
Influence of alcohol and acetaldehyde on cognitive function: findings from an alcohol clamp study in healthy young adults	9
	9
Issue Information	9
From Dark Paradise to limbic capitalism	9
Recreational N2O use: just laughing or really bad news?	9
The relationship between problematic gambling severity and engagement with gambling products: Longitudinal analysis of the Emerging Adults Gambling Survey	9
Author Index	9
How did investigations into spontaneous human combustion influence alcohol medicine? An examination of the medical and literary discussions that brought the two together	9
Prenatal smoking, alcohol and caffeine exposure and maternal‐reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic ris	9
Reducing problematic alcohol use in employees: economic evaluation of guided and unguided web‐based interventions alongside a three‐arm randomized controlled trial	9
	9
Association of fully branded, standardized packaging and limited flavor and brand descriptors of e‐liquids with interest in trying products among youths in Great Britain	9
Issue Information	9
Issue Information	9
Issue Information	9
Effectiveness of mobile smoking cessation treatment with 1‐week nicotine replacement therapy sampling at outdoor smoking hotspots: A cluster randomized controlled trial	9
Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference‐in‐differences analysis of a pay‐for‐performance scheme in England	9
The relationship between age at first drink and later risk behaviours during a period of youth drinking decline	9
Commentary on Nikoo et al.: Challenges in protocol development to optimize outcomes of opium tincture maintenance treatment	9
Issue Information	9
New Books	9